Results 1 to 10 of about 18,928 (205)

The Japanese PCI Registry (J-PCI): 17 Years of Insights Into Quality, Outcomes, and Practice Evolution. [PDF]

JACC Asia
Takahashi S, Kohsaka S, Yamaji K, Amano T, Kozuma K, J-PCI Registry Investigators.   +5 more
europepmc   +1 more source

Antiplatelet Therapy in Atrial Fibrillation Patients on Direct Oral Anticoagulants Undergoing Percutaneous Coronary Intervention: Which and How. [PDF]

J Clin Med
Martini L, Lisi M, Pompei G, Arioti M, Bendandi F, Henein MY, Cameli M, Rubboli A.   +7 more
europepmc   +1 more source

The Stability of Drugs Commonly Used in Intensive Care Units Co-Administered via Feeding Tube and Its Dependence on pH: An in vitro Study. [PDF]

Pharmacology
Papiež A, Suk P, Baránková R, Hančlová P, Šrámek V, Odehnalová K.   +5 more
europepmc   +1 more source

Comparative Effects of P2Y12 Inhibitors on Thrombus Biology and Inflammatory Responses in Atherothrombotic Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Ullah N, Ali M, Dad Khan I, Khan M, Jamil H, Anthony N.   +5 more
europepmc   +1 more source

Implementing a CYP2C19-guided approach for prescribing dual antiplatelet therapy in acute coronary syndrome for patients undergoing percutaneous coronary intervention: a cost-effectiveness analysis

Mahboub-Ahari A, Hilton J, Rodrigues M, McDermott J, Body R, Newman WG, Payne K.   +6 more
europepmc   +1 more source

Effectiveness and Safety of Reduced-Dose Prasugrel in an East Asian Population: PRASFIT-ACS Emulation Using National Health Insurance Claims Data. [PDF]

Clin Pharmacol Ther
Huang LW, Wu YJ, Lin FJ, Wu CC, Huang HY, Wang CC, Li X.   +6 more
europepmc   +1 more source

Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. [PDF]

Clin Appl Thromb Hemost
Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA.   +10 more
europepmc   +1 more source

The risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel: systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Alamzaib SM, Maniya MT, Hazaveh S, Cheema AAA, Sultan W, Qatanani A, Mirza MO, Damito S, Kumar M, Hassan SA, Khan TJ.   +10 more
europepmc   +1 more source

Ticagrelor Paradox: Systematic Review and Network Meta-Analysis. [PDF]

J Am Heart Assoc
Watanabe A, Aikawa T, Miyamoto Y, Ueyama HA, Fujisaki T, Shoji S, Hosseini K, Slipczuk L, Briasoulis A, Kampaktsis PN, Wiley J, Secemsky EA, Iwagami M, Tsugawa Y, Kuno T.   +14 more
europepmc   +1 more source

Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome. [PDF]

Eur Heart J Cardiovasc Pharmacother
Galli M, Gragnano F, Valgimigli M.
europepmc   +1 more source